Raymond A. Rubin

5.2k citations
44 papers · 2.0k indexed · 2 hit papers · h-index 19
Topics
Hepatitis C virus research (16 papers)Liver Disease Diagnosis and Treatment (14 papers)Liver Disease and Transplantation (12 papers)
Partner nations
United StatesCanadaSpain

In The Last Decade

Raymond A. Rubin

43 papers receiving 1.9k citations

Hit Papers

Efficacy of boceprevir, an NS3 protease inhibitor, in com...201020262015202020102021100200300400500

Peers

Raymond A. Rubin
Comparison fields: 5 of 101
  • Hepatology 1.5k
  • Epidemiology 1.4k
  • Surgery 437
  • Infectious Diseases 266
  • Endocrinology, Diabetes and Metabolism 139
Replace Daniel S. Pratt with:
Daniel S. Pratt United States
M. Pleguezuelo United Kingdom
Albert Friedrich Stättermayer Austria
E B Keeffe United States
Vasiliki Arvaniti United Kingdom
Agostino Colli Italy
G. Clemente Spain
Edmondo Falleti Italy
John Goulis Greece
Obaid S. Shaikh United States
Raymond A. Rubin relative to Daniel S. Pratt United States Daniel S. Pratt's profile →
Citations per field
00.5×1.5×
Daniel S. Pratt · 1×
Citations per year

Countries citing papers authored by Raymond A. Rubin

Since Specialization
Citations

This map shows the geographic impact of Raymond A. Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond A. Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond A. Rubin more than expected).

Fields of papers citing papers by Raymond A. Rubin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond A. Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond A. Rubin. The network helps show where Raymond A. Rubin may publish in the future.

Co-authorship network of co-authors of Raymond A. Rubin

This figure shows the co-authorship network connecting the top 25 collaborators of Raymond A. Rubin. A scholar is included among the top collaborators of Raymond A. Rubin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymond A. Rubin. Raymond A. Rubin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 2
3 1
4 1
5 17
6 75
7 1
8 4
9
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trialbreakdown →
515
10 53
11 1
12 35
13 43
14 5
15 21
16 18
17 13
18 86
19 63
20
Acute esophageal obstruction: a unique presentation of a giant intramural esophageal leiomyoma.
3

About Raymond A. Rubin

Raymond A. Rubin is a scholar working on Hepatology, Transplantation and Epidemiology, having authored 44 papers that have together received 2.0k indexed citations. Recurring topics across this work include Hepatitis C virus research (16 papers), Liver Disease Diagnosis and Treatment (14 papers) and Liver Disease and Transplantation (12 papers). The work is most often cited by research in Hepatology (1.5k citations), Epidemiology (1.4k citations) and Infectious Diseases (266 citations). Raymond A. Rubin has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Steven K. Herrine, Ziv J. Haskal, Clifford A. Brass, Constantin Cope, Ira M. Jacobson, John M. Vierling, Paul Y. Kwo, Jonathan McCone, Natarajan Ravendhran and Lorenzo Rossaro. Their work appears in journals such as New England Journal of Medicine, The Lancet and Annals of Internal Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026